A Clinical Study of SHR-9539 in Patients With Multiple Myeloma

Clinical trial NCT06484777 · RECRUITING

Trial details

NCT number: NCT06484777
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2024-08-07
Primary completion: 2027-07-31
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.